TY - JOUR
T1 - Segmentation of ADPKD Computed Tomography Images with Deep Learning Approach for Predicting Total Kidney Volume
AU - Sheng, Ting Wen
AU - Onthoni, Djeane Debora
AU - Gupta, Pushpanjali
AU - Lee, Tsong Hai
AU - Sahoo, Prasan Kumar
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/1/22
Y1 - 2025/1/22
N2 -
Background: Total Kidney Volume (TKV) is widely used globally to predict the progressive loss of renal function in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Typically, TKV is calculated using Computed Tomography (CT) images by manually locating, delineating, and segmenting the ADPKD kidneys. However, manual localization and segmentation are tedious, time-consuming tasks and are prone to human error. Specifically, there is a lack of studies that focus on CT modality variation.
Methods: In contrast, our work develops a step-by-step framework, which robustly handles both Non-enhanced Computed Tomography (NCCT) and Contrast-enhanced Computed Tomography (CCT) images, ensuring balanced sample utilization and consistent performance across modalities. To achieve this, Artificial Intelligence (AI)-enabled localization and segmentation models are proposed for estimating TKV, which is designed to work robustly on both NCCT and Contrast-Computed Tomography (CCT) images. These AI-based models incorporate various image preprocessing techniques, including dilation and global thresholding, combined with Deep Learning (DL) approaches such as the adapted Single Shot Detector (SSD), Inception V2, and DeepLab V3+.
Results: The experimental results demonstrate that the proposed AI-based models outperform other DL architectures, achieving a mean Average Precision (mAP) of 95% for automatic localization, a mean Intersection over Union (mIoU) of 92% for segmentation, and a mean R2 score of 97% for TKV estimation.
Conclusions: These results clearly indicate that the proposed AI-based models can robustly localize and segment ADPKD kidneys and estimate TKV using both NCCT and CCT images.
AB -
Background: Total Kidney Volume (TKV) is widely used globally to predict the progressive loss of renal function in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Typically, TKV is calculated using Computed Tomography (CT) images by manually locating, delineating, and segmenting the ADPKD kidneys. However, manual localization and segmentation are tedious, time-consuming tasks and are prone to human error. Specifically, there is a lack of studies that focus on CT modality variation.
Methods: In contrast, our work develops a step-by-step framework, which robustly handles both Non-enhanced Computed Tomography (NCCT) and Contrast-enhanced Computed Tomography (CCT) images, ensuring balanced sample utilization and consistent performance across modalities. To achieve this, Artificial Intelligence (AI)-enabled localization and segmentation models are proposed for estimating TKV, which is designed to work robustly on both NCCT and Contrast-Computed Tomography (CCT) images. These AI-based models incorporate various image preprocessing techniques, including dilation and global thresholding, combined with Deep Learning (DL) approaches such as the adapted Single Shot Detector (SSD), Inception V2, and DeepLab V3+.
Results: The experimental results demonstrate that the proposed AI-based models outperform other DL architectures, achieving a mean Average Precision (mAP) of 95% for automatic localization, a mean Intersection over Union (mIoU) of 92% for segmentation, and a mean R2 score of 97% for TKV estimation.
Conclusions: These results clearly indicate that the proposed AI-based models can robustly localize and segment ADPKD kidneys and estimate TKV using both NCCT and CCT images.
KW - contrast computed tomography
KW - deep learning
KW - localization
KW - non-contrast computed tomography
KW - polycystic kidney disease
KW - segmentation
KW - total kidney volume
UR - https://www.scopus.com/pages/publications/85218879253
U2 - 10.3390/biomedicines13020263
DO - 10.3390/biomedicines13020263
M3 - 文章
C2 - 40002677
AN - SCOPUS:85218879253
SN - 2227-9059
VL - 13
JO - Biomedicines
JF - Biomedicines
IS - 2
M1 - 263
ER -